Leonard E. Post - 04 Oct 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Reporting relationship: Director
Issuer ticker: CGON
Reported as of: 04 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2024, 17:17:50 UTC
Prior SEC filing: 21 Jun 2024
Next SEC filing: 06 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post

Key filing fact

Leonard E. Post filed Form 4 for CG Oncology, Inc. (CGON) on 07 Oct 2024.

Key facts

This page summarizes Leonard E. Post's Form 4 filing for CG Oncology, Inc. (CGON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2024, 17:17.

Change

Previous filing in this sequence was filed on 21 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +15,600
Change %
Price: $0.000000
Shares after: 15,600
Date: 04 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,600
Exercise price: $36.63
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date.